Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment

Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer in the world. According to Barcelona Clinic Liver Cancer modified criteria, patients with early stage disease are candidate to radiofrequency ablation (RFA), while patients with intermediate stage HCC are usually treated by tran...

Full description

Saved in:
Bibliographic Details
Main Authors: Ranieri, Girolamo, Marech, Ilaria, Lorusso, Vito, Goffredo, Veronica, Paradiso, Angelo, Ribatti, Domenico, Gadaleta, Cosmo Damiano
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2014
Subjects:
Minireviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923023/
https://ncbi.nlm.nih.gov/pubmed/24574717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i2.486
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items